These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6140135)

  • 1. Cytochrome P-450-dependent oxidation of the 17 alpha-ethynyl group of synthetic steroids. D-homoannulation or enzyme inactivation.
    Schmid SE; Au WY; Hill DE; Kadlubar FF; Slikker W
    Drug Metab Dispos; 1983; 11(6):531-6. PubMed ID: 6140135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidation of 17 alpha-ethynylestradiol by human liver cytochrome P-450.
    Guengerich FP
    Mol Pharmacol; 1988 May; 33(5):500-8. PubMed ID: 3285175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism of a nitrogen-containing steroid by rat hepatocytes and hepatic subcellular fractions.
    Kedderis GL; Argenbright LS; Walsh JS; Smith JL; Stearns RA; Arison BA; Miwa GT
    Drug Metab Dispos; 1989; 17(6):606-11. PubMed ID: 2575495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro studies on the metabolic activation of the furanopyridine L-754,394, a highly potent and selective mechanism-based inhibitor of cytochrome P450 3A4.
    Sahali-Sahly Y; Balani SK; Lin JH; Baillie TA
    Chem Res Toxicol; 1996 Sep; 9(6):1007-12. PubMed ID: 8870989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of constitutive and phenobarbital-induced cytochrome P-450 isozymes during the sequential oxidation of benzphetamine. Explanation for the difference in benzphetamine-induced hydrogen peroxide production and 455-nm complex formation in microsomes from untreated and phenobarbital-treated rats.
    Jeffery EH; Mannering GJ
    Mol Pharmacol; 1983 May; 23(3):748-57. PubMed ID: 6865917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethynyl cleavage of 17 alpha-ethynylestradiol in the rhesus monkey.
    Raitano LA; Slikker W; Hill DE; Hadd HE; Cairns T; Helton ED
    Drug Metab Dispos; 1981; 9(2):129-34. PubMed ID: 6113111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism of the cytochrome P450 mechanism-based inhibitor N-benzyl-1-aminobenzotriazole to products that covalently bind with protein in guinea pig liver and lung microsomes: comparative study with 1-aminobenzotriazole.
    Woodcroft KJ; Webb CD; Yao M; Weedon AC; Bend JR
    Chem Res Toxicol; 1997 May; 10(5):589-99. PubMed ID: 9168258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mouse hepatic microsomal enzyme that catalyzes oxidation of 11-oxo-delta 8-tetrahydrocannabinol to delta 8-tetrahydrocannabinol-11-oic acid.
    Watanabe K; Hirahashi N; Narimatsu S; Yamamoto I; Yoshimura H
    Drug Metab Dispos; 1991; 19(1):218-21. PubMed ID: 1673402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3-ketocholanoic acid is the major in vitro human hepatic microsomal metabolite of lithocholic acid.
    Deo AK; Bandiera SM
    Drug Metab Dispos; 2009 Sep; 37(9):1938-47. PubMed ID: 19487251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Major isozymes of rat liver microsomal cytochrome P-450 involved in the N-oxidation of N-isopropyl-alpha-(2-methylazo)-p-toluamide, the azo derivative of procarbazine.
    Prough RA; Brown MI; Dannan GA; Guengerich FP
    Cancer Res; 1984 Feb; 44(2):543-8. PubMed ID: 6692359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism of progesterone and estradiol by microsomes and purified cytochrome P-450 RLM3 and RLM5.
    Cheng KC; Schenkman JB
    Drug Metab Dispos; 1984; 12(2):222-34. PubMed ID: 6144489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of cytochrome P-450 isozymes involved in the hydroxylation of dantrolene by rat liver microsomes.
    Jayyosi Z; Villoutreix J; Ziegler JM; Batt AM; De Maack F; Siest G; Thomas PE
    Drug Metab Dispos; 1993; 21(5):939-45. PubMed ID: 7902259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytochrome P450 inactivation during reductive metabolism of 1,1-dichloro-2,2,2-trifluoroethane (HCFC-123) by phenobarbital- and pyridine-induced rat liver microsomes.
    Ferrara R; Tolando R; King LJ; Manno M
    Toxicol Appl Pharmacol; 1997 Apr; 143(2):420-8. PubMed ID: 9144458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aryl acetylenes as mechanism-based inhibitors of cytochrome P450-dependent monooxygenase enzymes.
    Foroozesh M; Primrose G; Guo Z; Bell LC; Alworth WL; Guengerich FP
    Chem Res Toxicol; 1997 Jan; 10(1):91-102. PubMed ID: 9074808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in estrogen metabolism after chronic oral contraceptive administration in the rhesus monkey.
    Slikker W; Lipe GW; Sziszak TJ; Bailey JR
    Drug Metab Dispos; 1984; 12(2):148-53. PubMed ID: 6144478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism of the antimammary cancer antiestrogenic agent tamoxifen. I. Cytochrome P-450-catalyzed N-demethylation and 4-hydroxylation.
    Mani C; Gelboin HV; Park SS; Pearce R; Parkinson A; Kupfer D
    Drug Metab Dispos; 1993; 21(4):645-56. PubMed ID: 8104124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of cytochrome P450 2E1 in the metabolism of 1,1,2,3,3,3-hexafluoropropyl methyl ether.
    Köster U; Speerschneider P; Kerssebaum R; Wittmann H; Dekant W
    Drug Metab Dispos; 1994; 22(5):667-72. PubMed ID: 7835215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism of 2-amino-alpha-carboline. A food-borne heterocyclic amine mutagen and carcinogen by human and rodent liver microsomes and by human cytochrome P4501A2.
    Raza H; King RS; Squires RB; Guengerich FP; Miller DW; Freeman JP; Lang NP; Kadlubar FF
    Drug Metab Dispos; 1996 Apr; 24(4):395-400. PubMed ID: 8801053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CYP2C75-involved autoinduction of metabolism in rhesus monkeys of methyl 3-chloro-3'-fluoro-4'-{(1R)-1-[({1-[(trifluoroacetyl)amino]cyclopropyl}carbonyl)amino]ethyl}-1,1'-biphenyl-2-carboxylate (MK-0686), a bradykinin B1 receptor antagonist.
    Tang C; Carr BA; Poignant F; Ma B; Polsky-Fisher SL; Kuo Y; Strong-Basalyga K; Norcross A; Richards K; Eisenhandler R; Carlini EJ; Di Marco CN; Kuduk SD; Yu NX; Raab CE; Rushmore T; Frederick CB; Bock MG; Prueksaritanont T
    J Pharmacol Exp Ther; 2008 Jun; 325(3):935-46. PubMed ID: 18310472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced rates of cytochrome P450 metabolic-intermediate complex formation from nonmacrolide amines in rifampicin-treated rabbit liver microsomes.
    Franklin MR
    Drug Metab Dispos; 1995 Dec; 23(12):1379-82. PubMed ID: 8689947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.